Markets

U.S. open in 31 hrs, 47 mins
10,464.40
30.69
 
0.29%
2,176.05
6.87
 
0.32%
1,110.63
4.98
 
0.45%
100.844
0.25
 
0.25%
5,364.81
40.85
 
0.77%
9,383.24
-58.40
 
0.62%
22,369.61
-242.19
 
1.07%
0.0172
 
1.15%
-1.20
 
1.36%
1,194.30
7.30
 
0.61%
77.40
-0.56
 
0.72%
Get Free Stock Chart for:

Seattle Genetics 3Q loss narrows on partnerships

AP ONLINE
posted: 34 DAYS 8 HOURS AGO

BOTHELL, Wash. (AP) — Development-stage biotechnology company Seattle Genetics Inc. said Thursday its third-quarter loss narrowed on higher revenue from partnerships.

The company lost $19.8 million, or 21 cents per share, compared with a loss of $21.8 million, or 27 cents per share, during the same period a year prior. Revenue rose 44 percent to $11.6 million from $8.1 million.

Analysts polled by Thomson Reuters expected a loss of 25 cents per share on revenue of $9.4 million.

The company's key partnership is with Genentech Inc., now part of Roche. The companies are developing potential cancer treatments.

Shares of Seattle Genetics rose 12 cents to close at $9.85.

Bookmark:
COMMENTS ( 0 )
GOT SOMETHING TO SAY?
YOU'LL BE ASKED TO REGISTER OR SIGN IN BEFORE POSTING A COMMENT.
Make a Comment
Comment
 

Headlines From AOL Money & Finance Partners

CNBC
The Big Money
Smart Money
Kiplinger.com
The street

Visit Money & Finance for stock quotes, the web's best online portfolio manager and the latest business & financial news. Find out about every aspect of personal finance and money management, from finding the best mortgage rates and preventing identity theft to making money, saving money and investing money.